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• Fatigue
• Loss of appetite
• Weight loss
• Nausea + vomiting 
• Decreased QoL
• Depression
• Anxiety
• GI symptoms
• ↓ QoL
• ↓ oral intake
• Malnutrition
• Treatment 
cessation
• Mortality
What’s the issue?
Anti-CINV mechanisms for Ginger
Source: Marx, W., Ried, K., McCarthy, A., Vitetta, L., 
Sali, A., McKavanagh, D., Isenring, E. 2017. Ginger –
Mechanism of action in chemotherapy-induced 
nausea and vomiting: a review. Critical Reviews in 
Food Science and Nutrition, 57(1), 141-146. 
Evidence for Ginger for CINV
Standard recommendations for use of ginger for CINV in the 
clinical setting not warranted.
N=5 studies
Meta-analysis
No significant effect of 
ginger
N=7 studies
Qualitative analysis
Mixed support for use of 
ginger
Study Aim
To evaluate the efficacy
of ginger
supplementation in the 
prevention and
management of 
CINV.
5 electronic databases searched
From database inception to April 2018 
Data pooled (meta-analysis)
Study quality assessed (Cochrane ROB Tool)
Quality of body of evidence evaluated (GRADE)
Method
Included
• Any language
• Age >18 years
• Chemotherapy patients
• Intervention of ginger 
• Comparator of placebo or 
standard care alone
Method – Study Characteristics
Excluded
• Radiation
• Unable to be 
translated to English
• Receiving other 
interventions as 
comparator
Records identified through 
database searching 
(n=203)
Records screened 
title and abstract 
only
(n=210)
Full-text papers 
assessed for 
eligibility 
(n=37)
Papers included in 
qualitative synthesis
(n=18)
Papers included in 
meta-analysis
(n=13)
Additional records 
identified through 
snowballing
(n=2)
Additional records 
identified in previous SLR 
(n=5)
Results – Search
Duplicates removed (n=89)
Records excluded (n=84)
Full-text papers excluded (n=19)
Results – Study Quality (Risk of Bias)
Results – Study Samples
Total No. participants 1652
Sample sizes 20-375
Female 64%
Country Iran (n=6 studies), Thailand (n=4), USA (n=2), Turkey (n=2), Italy, Indonesia, 
China, Australia (n=1)
Cancer Breast (n=9), lung (n=2), ovarian (n=2), other (gastrointestinal, haematological, 
unspecified) (n=5)
CTx type Platinum-based (n=8); anthracycline-based (n=6); unspecified (n=4)
CTx emetogenicity Moderate and/or high (n=8); unspecified (n=10)
CTx regimen Single-day (n=6); unspecified (n=12)
Anti-emetics Coticosteroid + 5-HT3 receptor antagonist (n=6);
Coticosteroid + 5-HT3 receptor antagonist + other (n=7); aprepitant + 5-HT3
receptor antagonist (n=2); unspecified (n=3)
Any dose for >3-days 
duration significantly 
reduced odds of overall 
nausea incidence by 27%. 
GRADE level: very low
Results – Nausea Incidence
>1g/day for any duration 
significantly reduced odds 
of overall nausea incidence 
by 42%.
GRADE level: very low
Results – Vomiting Incidence
Any dose for >3-days 
duration significantly 
reduced odds of overall 
nausea by 40%. 
GRADE level: low
≤1g/day for any duration 
significantly reduced 
odds of overall vomiting 
incidence by 30%.
GRADE level: low
• Clinical heterogeneity
• Missing Data 
• Small sample size in some studies
• Limited confidence in estimated effect
Limitations
Ginger supplementation for >3-days may improve CINV. 
Existing research around dosage remains inconsistent.
…more research!
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